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ABSTRACT
The monomer triethyleneglycoldimethacrylate
(TEGDMA) is used as a diluent in many resin-
based dental materials. It was previously shown in
vitro that TEGDMA was released into the adjacent
biophase from such materials during the first days
after placement. In this study, the uptake,
distribution, and excretion of 14C-TEGDMA
applied via gastric, intradermal, and intravenous
administration at dose levels well above those
encountered in dental care were examined in vivo
in guinea pigs and mice as a test of the hypothesis
that TEGDMA reaches cytotoxic levels in
mammalian tissues. 14C-TEGDMA was taken up
rapidly from the stomach and small intestine after
gastric administration in both species and was
widely distributed in the body following
administration by each route. Most 14C was
excreted within one day as 14CO2. The peak
equivalent TEGDMA levels in all mouse and
guinea pig tissues examined were at least 1000-
fold less than known toxic levels. The study
therefore did not support the hypothesis.
KEY WORDS: TEGDMA, composite resin,
restorative materials, toxicity.
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Distribution and Excretion
of TEGDMA in Guinea Pigs
and Mice
INTRODUCTION
Desin-containing materials are used routinely in dental practice as direct
filling materials, fissure sealing agents, bonding resins, and resin cements.
Among the components of most bonding and restorative resins are (1) a
primary resin, usually 2,2-bis-(4-(2-hydroxy-3-methacryloxy-
propoxy)phenyl)propane (Bis-GMA), and (2) triethyleneglycol-
dimethacrylate (TEGDMA), which is included to compensate for the high
viscosity of the primary resin. Resin composites contain TEGDMA in
amounts from 15 to 25%, while bonding resins contain TEGDMA in the
range 30 to 55% (Nakabayashi and Takarada, 1992).
Direct evidence of TEGDMA release from composite resins and fissure
sealants into the biophase was provided by Tanaka et al. (1991), Gerzina and
Hume (1994), Hamid and Hume (1997), and Spahl et al. (1998). TEGDMA
can be expected to enter the body by two different routes after resin
placement: via the saliva and gastrointestinal tract, plus (if the material is
placed onto dentin) via the dentin and pulp (Hume and Gerzina, 1996).
To test the hypothesis that TEGDMA reaches cytotoxic levels in body
tissues, we have measured the uptake, distribution, and clearance of 14C-
TEGDMA administered by gastric tube and by subcutaneous injection in
guinea pigs and by the same routes and by intravenous injection in mice.
MATERIALS & METHODS
14C-TEGDMA was purchased from Prins-Maurits-Laboratorium (Rijswijk,
The Netherlands), dissolved in dichloromethane, and stored at -20°C.
Unlabeled TEGDMA was obtained from ESPE Dental AG (Seefeld,
Germany).
Guinea Pigs
The University of Munich Committee on Animal Research, ensuring
humane practices, approved the experiments (permission no. 211-2531-
66/94). Adult male guinea pigs (Dunkin-Hartley Pirbright white strain)
were fed a standard diet and water ad libitum. Sixteen guinea pigs were
allotted to 4 groups of 4 animals each. Each animal was put into a
separate metabolic cage 3 days before and food was removed 12 hrs
before the experiment. Each animal received 0.02 mmol/kg 14C-
TEGDMA (0.7 kBq/g) either by subcutaneous injection (group 1) or via
gastric tube (group 2). Control animals (groups 3 and 4) received 0.9%
NaCl solution correspondingly. Feces and urine were collected at 1, 2, 4,
6, 8, 12, and 24 hrs after 14C-TEGDMA administration, and the 14C-
radioactivity was measured as described below. At 24 hrs, the animals
were killed in ether. Organs taken immediately and tested were: liver,
kidney, blood, skin, brain, heart, spleen, lung, muscle, testes, eyes, bone,
nerve tissue, spinal cord, wall of stomach, content of stomach, wall of
ileum + jejunum, content of ileum + jejunum, wall of colon, content of
colon, wall of caecum, content of caecum, wall of gall bladder, and fat
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tissue. Organs were immediately washed with 2 x 10 mL
distilled H20, with the wash-water saved, and then the
tissues were weighed and homogenized. Tissues were
dissolved in tetraethylammoniumhydroxide (TEAH) (20%)
in aqueous solution with Omni-Szintisol® (both from Merck,
Darmstadt, Germany). 14C was determined with a liquid
scintillation counter (2500 TR, Canberra-Packard, Dreieich,
Germany). Data were presented as mean + standard error of
the mean (SEM) of the administered dose. Statistical
significance of differences between experimental groups
was determined by means of the Bonferroni-Holm t test
(Forst, 1985).
A second set of 16 guinea pigs was treated as described
above, with the addition that each animal was kept in a closed
chamber with controlled airflow. The exhaled air was captured
during the 24-hour experimental period by flowing through 7
bottles, one behind the other, filled with 250 mL ice-cold 5 N
NaOH (see Fig.). 14C02 was captured as Na214C3, and the
total 14C activity was determined.
Mice
The UCLA Committee on Animal Research, ensuring
humane practices, approved the experiments. Twenty-three
Balb-C, female mice, 6 to 7 weeks of age, were obtained
from the UCLA animal colony and housed and fed routinely
before the administration of 10 nanomoles (50 nCi total
activity, 100 nmol/mL, 0.1 mL administered volume) 14C-
TEGDMA by one of three routes: (1) by gastric tube, (2) into
the tail vein, or (3) by intradermal injection beneath shoulder
skin. Animals were killed by decapitation at various times
after administration (see Tables 2 and 3), and samples of
blood and various tissues (see Tables) were taken. Tissues,
blood, and feces were weighed then dissolved in Hionic-
Fluor (Packard, Meridien, CT, USA) and urine samples in
Ultima Gold LLT (Packard), and 14C was determined by
means of a liquid scintillation counter (LS6500, Beckman
Coulter, Fullerton, CA, USA). Data were expressed as
femtomoles/mg TEGDMA on the assumption that 14C
represented 14C-TEGDMA.
RESULTS
Total 14C Recovery
from Guinea Pigs after 24 Hrs
Table 1 summarizes data for 14C
excretion in guinea pigs via the urine,
feces, and in exhaled carbon dioxide
during 24 hrs after 14C-TEGDMA
administration and 14C distribution in
the organs collected at the time the
guinea pigs were killed, expressed as a
percentage of the 14C-TEGDMA dose
administered. During the first 24 hrs
after administration, guinea pigs
exhaled 14CO2, equivalent to about
60% of the 14C-TEGDMA admini-
stered with each route. About 15%
was excreted in the urine and about
5% remained in the tissues at 24 hrs.
The total 14C recovery was more than
80% of the 14C-TEGDMA dose
administered.
Table 1. 14C Excretion and Summed 14C Distribution in Guinea Pigs
Percentage of the 14C-TEGDMA Dose Administereda
Subcutaneous Gastric Tube
Mean SEM Mean SEM
Urine 16.5 1.2 15.1 3.6
Feces 0.3 0.1 0.5 0.1
Exhaled "4CO2 63.6 2.1 61.9 4.6
Organ wash-water 0.5 0.1 0.5 0.1
Summed organs 5.0 1.2 5.2 1.0
Total 14C recovery 85.9 4.9 83.2 4.1
a 14C excretion in guinea pigs via the urine, feces, and carbon
dioxide and summed 14C distribution in all organs 24 hrs
after administration, expressed as a percentage of the
administered dose.
Mouse-Gastric Administration
Table 2 shows the amounts of 14C expressed as the equivalent of
TEGDMA per milligram in tissue samples from each of 7
animals which were killed at the times shown after admin-
istration of 14C-TEGDMA (10 nanomoles total dose) by gastric
tube. Virtually all detectable 14C was cleared from the mice in
one day.
Mouse-intravenous Administration
Table 3 shows the amounts of 14C expressed as the equivalent of
TEGDMAper milligram in tissue samples from each of 8 animals
which were killed at the times shown after administration of 14C-
TEGDMA (10 nanomoles total dose) by intravenous injection.
Trace amounts of 14C were still present in the tissues tested after 2
days.
Mouse-Intradermal Administratn
Distribution and clearance of 14C were similar with this route
of administration to that with gastric administration. Virtually
all detectable 14C was cleared by one day after administration.
Table 2. Distribution of 14C-TEGDMA Over Time Following Gastric Administration in Mice
Time after Administration
Tissue 1 min 15min 30min 1 hr 3hrs 1 day 2days
Stomacha I 1 699b 2828 372 804 359 4 0
Blood 68 119 42 64 13 0 0
Brain 9 45 27 4 0 0 0
Heart 173 98 40 8 0 0 0
lntestinea 260 609 229 2 8 0 0
Kidney 74 342 213 63 26 0 0
Liver 530 271 175 15 9 0 0
Lung 85 100 46 1 1 0 0 0
Lymph node 16 221 50 18 32 0 0
Muscle 114 111 62 23 12 0 0
Spleen 104 118 60 46 5 0 0
Thymus 35 116 21 45 7 0 0
a Including contents.
b 14C expressed as the equivalent concentration of TEGDMA (femtomoles/mg) present in various
tissues in each of 7 mice killed at the times shown following administration of 14C-TEGDMA
(10 nanomoles total dose) by gastric tube.
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Table 3. Distri
Tissue
Blood
Brain
Heart
ntesti neb
Kidney
Liver
Lung
Lymph node
Muscle
Spleen
Stomachb
Thymus
14C expr,
tissues in
(10 nanc
b Including
DISCUSSIC
Thc admirnistcied dose levels were chosein to cxceed
substanitially the body-weight-adj uisted dose levels rclative to
huMaIs lor Tl (i[)MA released from composite resin
restorations. For gUillCa pigs. wc uscd the data of Spahl ci a!.
( 1998), w ho showed that the comimier-cial compositc
SupCIluxI provided 1 .4 mmiloles TEGDMA from 100 g of
composite, ai amounlt that wLould bc used wheln maniy tecth
are restoi-ed simultaniCously. For the ImlOUSC, we used the data
of (ier,'ina ancd I Iuime ( 1996), who showed that on the order of
0.5 pimoles of TI DGDMA was rcleased fromil cach restoration
whieni the commercial composite Z/100" (3M) was used in
human rnmolar teeth. Despite the resultanit difference in
adiniiiistei-ed dose levels (20 pimol/kg for guinea pigs v's. 0.5
pimol/kg lor Imlice), the data on distributioni and clcaranice for
the two species w.rcveecry similar.
The body-weight-adjusted dose of TEDGMA administered
glucoeICogcicsis in kidncy cells ( Reichl ei zl. 999b).
Brain levels of '4C following administiation by gastric tubc
appeared to be markedly lower thall thosc of othel tissues,
indicating that 4C-TEGDMA adminiiste-ed by that route did
not cross the blood-brain barricr well. The mrajor route of
uptake in humnans followinig filling placemnent is very likely to
be via the saliva and stomacih. Followinlg intrave nous
administiationi, brain levels were initially highier than those il
blood and mlOSt otheIl tissucs, indicating selectiVe Liptake across
the blood-braini barrier. I lowevcer, the peak concciti atioiis
obsersved were far below any knowin toxic level. Therc is no
knowin cquivaleClt to intravenious application inl cClinical usc.
AssuLiig that the metabolism and cleiaraice of
TFGDMA in humans arc similar to thosc of guilnca pigs and
ImlicC, it is therefoie extreilmely un1likely that T (GDMA
ricleased fi-om restorative materials in hu1maIs could have
systemic toxic effects.
Figure. Metabolic cage with controlled airflow for capturing 14CO2 Exhaled carbon dioxide was captured by the pumping of the exholed air
through bottles 1 to 7 each filled with ice-cold 5 N NaOH.
bution of 14C-TEGDMA Over Time Following Intravenous Administration in Mice was Illoic than 5() timcs highici than
that whiichi a humanlia dental patient
Time after Administration would reccive. I lowcvcr. the highiest
5 min 15 min 30 min 1 hr 3 hrs 6 hrs 1 day 2 days lcvels of TFGDMA obscrvcd il tissuc
samilples takenI flroim Imlice 53 nM in
2800 128 136 46 23 17 8 5 liver I mrin after gastric placemcilt and
620 429 474 502 168 84 8 1 63 nM in braini 5 mill after illtrailVenOUS
180 91 74 36 33 33 20 3 illjCCtiO ac approximlately 10,000-
34 17 19 33 16 6 2 2 fold less thani the knowin toxic Icvel for
412 531 400 140 68 26 9 2 TEGDMA (Hfanks ei t. 1991; Saygili
65 41 57 23 12 7 3 3 et al., 1992; Reichl ei ohl, 1999a).
228 172 154 78 45 30 12 9 Simlilarly. the highest I4Aj colicentra-
293 146 59 110 40 61 48 10 tion in the spontallCOuS UlinlC ill eUinea
140 103 44 44 43 14 8 0 pigs was founld to be 0.2 mimlol/L
179 117 90 77 46 26 18 2 T EGDMA equivalent, 4 hl-s after thc
- 48 37 55 42 18 13 1 subcutanicous 4'C application. Peak
125 30 42 106 91 48 41 14 levels in blood and kidney tissnc in
IlliCC OCCUrred nnLCT eairlici thall this
essed as the equivalent concentration of TEGDMA (femtomoles/mg) present in various (see Tables 2 and 3). This is consisteint
each of 8 mice killed at the times shown following administration of 14C-TEGDMA witih the knowrn tiime dynamnics of ulrineDmoles total dose) by injection into the tail vein.
contents. produntion and the ariable but
expectcd dclay beforc UlilnC rileasc.
The peak Uriillaly level obsersved was)N aboLit one-tenithi ol the concentration that depressed
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